ABSTRACT
El proyecto HapMap ha generado información y preguntas sobre la diversidad genética en las distintas poblaciones del mundo. En las últimas décadas, proyectos como la elucidación del genoma del mestizo mexicano han revelado las distancias genéticas entre mestizos y amerindios en México. Cerca de 20 genes son actualmente estudiados en paneles comerciales asociados al metabolismo de fármacos, uno de ellos el gen que expresa la enzima CY P2C19, la cual metaboliza cerca de 26 fármacos de importancia clínica. El objetivo fue revisar la literatura científica en Google Scholar, PubMed y ScienceDirect que reporta resultados sobre estudios farmacogenéticos en Guatemala, otros que presentan hallazgos sobre distancias genéticas en el guatemalteco y se compara con lo que se conoce de otras poblaciones del continente y el mundo, haciendo énfasis en CY P2C19. El mestizaje en Guatemala fue único, por ello es importante investigar sus variantes alélicas asociadas al metabolismo de fármacos, para permitir una terapéutica más efectiva y segura que mejore la calidad de vida del guatemalteco.
The HapMap project has generated information and queries about genetic diversity in the different populations around the world. In recent decades, research projects such as the elucidation of the genome of the Mexican Mestizo, have exposed the genetic distances between mestizos and Amerindians in Mexico. About 20 genes are currently studied in commercial panels associated with drug metabolism. One of them CY P2C19, that expresses the CY P2C19 enzyme, that metabolizes about 26 drugs of clinical importance. The objective was to review the scientific literature in Google Scholar, PubMed and ScienceDirect that reports results on pharmacogenetic studies in Guatemala, others that presented findings over genetic distances in Guatemala, as well as a comparison with the knowledge about other populations of the continent and world, with emphasis in CY P2C19 gen. Miscegenation in Guatemala was unique and is important to investigate the Guatemalan allelic variants associated with drug metabolism to allow a more effective and safe therapeutic and improve their quality of life.
Subject(s)
Humans , Pharmacogenetics , Cytochrome P450 Family 19 , American Indian or Alaska Native/genetics , Pharmacogenomic Testing , Guatemala , Metabolism/drug effectsABSTRACT
El reposicionamiento de fármacos como la derivatización química, que se han aplicado en los estudios de descubrimiento y diseño de fármacos contra el SARS-CoV-2, dependen del ciclo de vida del virus, las dianas moleculares identificadas y un diseño basado en su estructura e interacciones moleculares. Se realizó una revisión extensa en las bases de datos públicas e institucionales RSCB-Protein Data Bank, ZINC, NCBI (PubMed, PMC), PubChem, Science Direct e instituciones como CDC, NIH y revistas científicas especializadas sobre los avances en la búsqueda de nuevas moléculas contra el nuevo coronavirus basadas en estudios in silico, detectándose más de 40,000 publicaciones sobre SARS-CoV-2 y cerca de 200 relacionadas a dichos estudios, las consideradas más relevantes fueron analizadas e incluidas en este artículo. Su análisis evidencia el avance acelerado de las herramientas computacionales y fortaleza del diseño de fármacos asistido por computadora (in silico approach) para la generación de nuevas moléculas con posibilidad de ser activas contra COVID-19 y presenta las principales dianas moleculares sobre la que actúan estos agentes con potencial antiviral.
The search of new applications for approved drugs by the regulatory authorities around the world, as well as their chemical derivatization in the search for new and effective drugs against SARS-CoV-2 depends of the viral life cycle, action of the drug and a receptor-based design. We performed a deep bibliographic research in peer reviewed scientific journals, data bases RSCB-Protein Data Bank, ZINC, NCBI (PubMed, PMC), PubChem, Science Direct and institutions (CDC, NIH) in the search of new molecules tested in silico against the novel coronavirus. As a result, we found more than 40,000 research papers related to SARS-CoV-2 and nearby 200 look on in silico studies, taking into consideration for this work all the more relevant for us, evidenced the accelerated advance and strength of the drug design assisted by computer (in silico approach) to develop new molecules that can be effective against COVID-19 and, at the same time, it exposes the main molecular targets.
Subject(s)
Humans , Computer Simulation , Coronavirus Infections/therapy , Betacoronavirus , SARS-CoV-2 , Antiviral Agents/analysis , Pharmaceutical Preparations/analysis , Drug Design , COVID-19ABSTRACT
Um fator limitante nas primeiras fases do cultivo do jundiá (Rhamdia quelen Quoy e Gaimard, 1824) é a presença da ictioftiríase. Os ácidos graxos poliinsaturados (PUFAs) presentes na dieta possuem uma potente atividade imuno-moduladora, e esta atividade depende da espécie analisada e da quantidade/qualidade dos PUFAs da dieta. O objetivo do presente estudo foi avaliar a resposta fisiológica de alevinos de jundiá, alimentados com diferentes fontes de ácidos graxos, quando parasitados pelo protozoário Ichthyophthirius multifiliis (Fouquet, 1876). Alevinos de jundiá (7,6±0,8g) alimentados durante sete semanas com cinco dietas contendo diferentes fontes lipídicas: óleos de peixe, linhaça e milho foram expostos ao protozoário. No quinto dia a presença da doença foi detectada. Amostras de sangue foram coletadas e sobrevivência e graus de infestação foram estimados. As diferentes dietas afetaram a sobrevivência dos alevinos, sendo que alevinos que consumiram dietas com óleo de peixe apresentaram uma maior sobrevivência. O hematócrito e o grau de infestação não apresentaram diferença estatística significativa entre os tratamentos, entretanto a contagem diferencial dos leucócitos registrou diferença. Os resultados mostraram pela primeira vez no jundiá que, diferentes fontes lipídicas produzem respostas fisiológicas diversas, podendo representar uma alternativa ao tratamento da doença. Novos estudos deverão ser realizados no sentido de aprofundar o conhecimento aqui gerado.
A limiting factor in the early stage of the jundiá (Rhamdia quelen Quoy; Gaimard, 1824) culture is the presence of diseases such as ichthyophthiriasis or "Ich". Dietary polyunsaturated fatty acids (PUFAs) have a potent immunomodulatory activity; and this activity depend of the fish species, quantity/quality of the dietary PUFAS. The aim of this study was evaluate the physiologic response ofjundiá, rather fed diets with different sources of fatty acids when challenge to Ich disease. Fingerlings ofjundiá (7.6±0.8g) were fed during seven weeks with five diets with a different lipid source: fish, linseed and corn oils. Then, the fish were challenged with the Ichthyophthirius multifiliis (Fouquet, 1876). On the 5th day, the presence of the disease was detected. Survival rate, blood samples and infection grade were recorded. Diets affect the survival rate of fingerlings, thus fish fed with diet with fish oil showed a higher survival. Hematocrit and infestation grade no recorder differences among treatment. The differential analysis of white blood cells shows difference. The results point out, at first time injundiá, that dietary lipids caused diversity physiologic response, this may be represent an opportunity for the disease treatment. New studies must be carrying out to deep knowledge found.